Open AccessP1218: FIRST‐IN‐HUMAN STUDY OF CD19/BCMA DUAL‐TARGETING FAST CAR‐T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN'S LYMPHOMA
Author(s) -
Chen X.,
Ping Y.,
Li L.,
Zhang L.,
Zhang X.,
Huang J.,
Sersch M.,
Wang Z.,
Song D.,
Wang H.,
Shen L.,
Zhao W.,
Zhang H.,
Zhang M.,
Zhang Y.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847736.14020.3e
Subject(s) - cytokine release syndrome , medicine , chimeric antigen receptor , tolerability , lymphoma , cd19 , b cell , oncology , antigen , immunology , t cell , adverse effect , immune system , antibody